All Insights
Showing 1 - 12 of 621
Regulatory Outlook
Fintech, digital assets, payments and consumer credit | UK Regulatory Outlook February 2026
New cryptoassets regulatory regime expected for the UK in 2027 | FCA launches Mills Review into how AI will reshape
Regulatory Outlook
Digital regulation | UK Regulatory Outlook February 2026
UK: Online safety and age assurance | UK government to consult on social media ban for children | Online Safety
Regulatory Outlook
Cyber security | UK Regulatory Outlook February 2026
European Commission proposes new cybersecurity package | UK and Japan launch strategic cyber partnership | UK government publishes ambassador scheme
Regulatory Outlook
Artificial intelligence | UK Regulatory Outlook February 2026
UK: AI Opportunities Action Plan: one year on | AI and copyright: recent comments from the government | New criminal
Data protection and privacy regulation
UK ICO explains the Data (Use and Access) Act's new data protection complaints requirements
With less than six months until new obligations take effect, guidance offers controllers practical steps for compliance
Games and interactive entertainment
Hands off the gold: what the UK Property (Digital Assets) Act holds for in-game 'items' and digital accounts
The interactive entertainment industry is focusing on questions around legal property and on its contractual provisions
Life Sciences and Healthcare
Draft EU medtech revisions adjust importer and distributor roles to support supply chain resilience
Digital obligations, leaner repackaging rules and new shortage reporting tools may evolve supply chain responsibilities
Life Sciences and Healthcare
Data-driven digital health businesses challenged with balancing AI advances and tighter regulation in 2026
Hyper-personalisation, data interoperability and AI are among 2025's fast-evolving areas to continue to watch this year
Life Sciences and Healthcare
EU MDR and IVDR poised to remain main framework for medical AI in draft AI interface reforms
Lex specialis treatment, integrated notified body reviews and clarified duties are designed to limit overlapping regulation of medical AI
Life Sciences and Healthcare
EU digital by default medtech plans signal shift in submissions, product information and online sales
E-submissions, digital documentation and clarified Eudamed and UDI duties to steer medtech towards fuller digitalisation
Life Sciences and Healthcare
Planned EU medtech changes and codified Helsinki procedure support consistent qualification and classification
EU coordination, expert panel opinions and targeted down classification are proposed to harmonise risk based outcomes
Corporate
Confidence in a changing global market: 2025 dealmaking themes and 2026 market opportunities
The global transactional market demonstrated resilience amid complexity in 2025 as it staged a measured recovery
